Anogenital warts (AGWs) rank among the most frequent sexually transmitted infections in
young adults. They are benign lesions, but they pose a significant economic cost to health …

Background Assessing the impact and effectiveness of HPV vaccines on anogenital warts in
the United States can provide early indication of the success of vaccination programs as well …

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide
and ano-genital warts (AGWs) are highly infectious. This virus is transmitted through sexual …

In Québec province in Canada, a public school‐based and catch‐up HPV vaccination
programs with the quadrivalent vaccine have been introduced in September 2008 for girls …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Background Human papilloma virus (HPV) types 6 and 11 account for 90 percent of
anogenital warts (AGW). Assessment of a potential reduction of the incidence of AGW …

Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Anogenital warts (AGWs) are a very common disease. They are caused mostly by low-risk
human papillomaviruses (HPV) 6 and 11, particularly the former. Clinical presentation is …

Background: A vaccine has recently been licensed in many countries that protects against
the human papillomavirus types 6, 11, 16, and 18. Types 6 and 11 account for approximately …

Introduction The quadrivalent HPV vaccine is highly effective in primary prevention of
anogenital warts (AGWs). However, there is lack of systematic review in the literature of the …